Journal of International Reproductive Health/Family Planning ›› 2024, Vol. 43 ›› Issue (6): 453-457.doi: 10.12280/gjszjk.20240147
• Original Article • Previous Articles Next Articles
WANG Yue, TANG Cen, LI Ya-jin, HU Wan-qin()
Received:
2024-04-01
Published:
2024-11-15
Online:
2024-11-12
Contact:
HU Wan-qin, E-mail: hwq2017@126.com
WANG Yue, TANG Cen, LI Ya-jin, HU Wan-qin. Risk Factors of Adverse Pregnancy Outcomes in Patients with Undifferentiated Connective Tissue Disease and Construction of A Nomogram Model for Predicting[J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 453-457.
Add to citation manager EndNote|Ris|BibTeX
指标 | 结局良好组 (n=64) | 结局不良组 (n=44) | t或 χ2或Z | P |
---|---|---|---|---|
年龄(岁) | 31.70±3.67 | 32.77±4.21 | 1.401 | 0.164 |
BMI(kg/m2) | 21.32±2.50 | 22.91±3.40 | 2.805 | 0.006 |
IVF | 13(12.0) | 17(15.7) | 4.364 | 0.037 |
不良妊娠史 | 32(29.6) | 25(23.1) | 0.486 | 0.486 |
发生2次以上不良妊娠 | 24(22.2) | 13(12.0) | 0.733 | 0.392 |
凝血功能异常 | 3(2.8) | 7(6.5) | - | 0.087* |
心功能不全 | 2(1.9) | 6(5.6) | - | 0.060* |
低蛋白血症 | 17(15.7) | 19(17.6) | 3.241 | 0.072 |
血小板减少 | 4(3.7) | 2(1.9) | - | 1.000* |
贫血 | 13(12.0) | 8(7.4) | 0.076 | 0.783 |
尿蛋白升高 | 2(1.9) | 8(7.4) | - | 0.014* |
妊娠期高血压 | 7(6.5) | 4(3.7) | - | 1.000* |
子痫前期 | 2(1.9) | 10(9.3) | - | 0.003* |
泼尼松 | 22(20.4) | 7(6.5) | 4.527 | 0.033 |
羟氯喹 | 35(32.4) | 27(25.0) | 0.475 | 0.491 |
阿司匹林 | 24(22.2) | 18(16.7) | 0.128 | 0.721 |
低分子肝素 | 35(32.4) | 24(22.2) | 0.000 | 0.988 |
总蛋白(g/L) | 64.68±6.78 | 62.56±8.21 | 1.466 | 0.146 |
白蛋白(g/L) | 34.45(32.05,36.60) | 31.70(29.75,35.18) | 2.861 | 0.004 |
PT(s) | 11.10(10.60,11.50) | 11.00(10.63,11.58) | 0.194 | 0.864 |
APTT(s) | 25.90(24.63,27.30) | 26.80(25.53,28.60) | 1.861 | 0.063 |
FIB(g/L) | 4.18±0.77 | 4.37±1.31 | 0.932 | 0.354 |
TT(s) | 15.38±0.82 | 16.11±1.03 | 4.050 | 0.001 |
IgG(g/L) | 9.11±2.26 | 9.40±2.41 | 0.583 | 0.561 |
IgA(g/L) | 1.47(1.19,1.80) | 1.61(1.39,2.39) | 1.973 | 0.048 |
IgM(g/L) | 1.30±0.62 | 1.26±0.51 | 0.360 | 0.720 |
C3(g/L) | 1.00±0.17 | 1.02±0.21 | 0.532 | 0.596 |
C4(g/L) | 0.19(0.17,0.24) | 0.19(0.15,0.24) | 0.508 | 0.611 |
ANA+ | 42(38.9) | 24(22.2) | 1.347 | 0.246 |
抗RNP抗体+ | 3(2.8) | 5(4.6) | - | 0.267* |
抗SSA抗体+ | 5(4.6) | 6(5.6) | 0.967 | 0.350 |
抗SSB抗体+ | 3(2.8) | 1(0.9) | - | 1.000* |
抗dsDNA抗体+ | 1(0.9) | 0 | - | 1.000* |
APL+ | 14(13.0) | 16(14.8) | 2.728 | 0.099 |
指标 | 结局良好组 (n=64) | 结局不良组 (n=44) | t或 χ2或Z | P |
---|---|---|---|---|
年龄(岁) | 31.70±3.67 | 32.77±4.21 | 1.401 | 0.164 |
BMI(kg/m2) | 21.32±2.50 | 22.91±3.40 | 2.805 | 0.006 |
IVF | 13(12.0) | 17(15.7) | 4.364 | 0.037 |
不良妊娠史 | 32(29.6) | 25(23.1) | 0.486 | 0.486 |
发生2次以上不良妊娠 | 24(22.2) | 13(12.0) | 0.733 | 0.392 |
凝血功能异常 | 3(2.8) | 7(6.5) | - | 0.087* |
心功能不全 | 2(1.9) | 6(5.6) | - | 0.060* |
低蛋白血症 | 17(15.7) | 19(17.6) | 3.241 | 0.072 |
血小板减少 | 4(3.7) | 2(1.9) | - | 1.000* |
贫血 | 13(12.0) | 8(7.4) | 0.076 | 0.783 |
尿蛋白升高 | 2(1.9) | 8(7.4) | - | 0.014* |
妊娠期高血压 | 7(6.5) | 4(3.7) | - | 1.000* |
子痫前期 | 2(1.9) | 10(9.3) | - | 0.003* |
泼尼松 | 22(20.4) | 7(6.5) | 4.527 | 0.033 |
羟氯喹 | 35(32.4) | 27(25.0) | 0.475 | 0.491 |
阿司匹林 | 24(22.2) | 18(16.7) | 0.128 | 0.721 |
低分子肝素 | 35(32.4) | 24(22.2) | 0.000 | 0.988 |
总蛋白(g/L) | 64.68±6.78 | 62.56±8.21 | 1.466 | 0.146 |
白蛋白(g/L) | 34.45(32.05,36.60) | 31.70(29.75,35.18) | 2.861 | 0.004 |
PT(s) | 11.10(10.60,11.50) | 11.00(10.63,11.58) | 0.194 | 0.864 |
APTT(s) | 25.90(24.63,27.30) | 26.80(25.53,28.60) | 1.861 | 0.063 |
FIB(g/L) | 4.18±0.77 | 4.37±1.31 | 0.932 | 0.354 |
TT(s) | 15.38±0.82 | 16.11±1.03 | 4.050 | 0.001 |
IgG(g/L) | 9.11±2.26 | 9.40±2.41 | 0.583 | 0.561 |
IgA(g/L) | 1.47(1.19,1.80) | 1.61(1.39,2.39) | 1.973 | 0.048 |
IgM(g/L) | 1.30±0.62 | 1.26±0.51 | 0.360 | 0.720 |
C3(g/L) | 1.00±0.17 | 1.02±0.21 | 0.532 | 0.596 |
C4(g/L) | 0.19(0.17,0.24) | 0.19(0.15,0.24) | 0.508 | 0.611 |
ANA+ | 42(38.9) | 24(22.2) | 1.347 | 0.246 |
抗RNP抗体+ | 3(2.8) | 5(4.6) | - | 0.267* |
抗SSA抗体+ | 5(4.6) | 6(5.6) | 0.967 | 0.350 |
抗SSB抗体+ | 3(2.8) | 1(0.9) | - | 1.000* |
抗dsDNA抗体+ | 1(0.9) | 0 | - | 1.000* |
APL+ | 14(13.0) | 16(14.8) | 2.728 | 0.099 |
因素 | β | SE | Wald χ2 | P | OR | 95%CI |
---|---|---|---|---|---|---|
子痫前期 | 2.214 | 0.938 | 5.130 | 0.024 | 8.361 | 1.331~52.527 |
BMI(kg/m2) | 0.211 | 0.102 | 4.258 | 0.039 | 1.236 | 1.011~1.510 |
TT(s) | 0.636 | 0.303 | 4.400 | 0.036 | 1.889 | 1.043~3.423 |
IgA(g/L) | 1.108 | 0.517 | 4.590 | 0.032 | 3.027 | 1.099~8.340 |
白蛋白(g/L) | -0.193 | 0.084 | 5.347 | 0.021 | 0.842 | 0.700~0.971 |
因素 | β | SE | Wald χ2 | P | OR | 95%CI |
---|---|---|---|---|---|---|
子痫前期 | 2.214 | 0.938 | 5.130 | 0.024 | 8.361 | 1.331~52.527 |
BMI(kg/m2) | 0.211 | 0.102 | 4.258 | 0.039 | 1.236 | 1.011~1.510 |
TT(s) | 0.636 | 0.303 | 4.400 | 0.036 | 1.889 | 1.043~3.423 |
IgA(g/L) | 1.108 | 0.517 | 4.590 | 0.032 | 3.027 | 1.099~8.340 |
白蛋白(g/L) | -0.193 | 0.084 | 5.347 | 0.021 | 0.842 | 0.700~0.971 |
[1] | Dyball S, Rodziewicz M, Mendoza-Pinto C, et al. Predicting progression from undifferentiated connective tissue disease to definite connective tissue disease: A systematic review and meta-analysis[J]. Autoimmun Rev, 2022, 21(11):103184. doi: 10.1016/j.autrev.2022.103184. |
[2] | 陈乐锋, 戴冽. 妊娠合并未分化结缔组织病的管理[J]. 中华产科急救电子杂志, 2019, 8(2):97-102. doi: 10.3877/cma.j.issn.2095-3259.2019.02.008. |
[3] | Mosca M, Tani C, Vagnani S, et al. The diagnosis and classification of undifferentiated connective tissue diseases[J]. J Autoimmun, 2014, 48/49:50-52. doi: 10.1016/j.jaut.2014.01.019. |
[4] | Martin Calderon L, Pope JE. Precursors to Systemic Sclerosis and Systemic Lupus Erythematosus: From Undifferentiated Connective Tissue Disease to the Development of Identifiable Connective Tissue Diseases[J]. Front Immunol, 2022,13:869172. doi: 10.3389/fimmu.2022.869172. |
[5] | Bender Atik R, Christiansen OB, Elson J, et al. ESHRE guideline: recurrent pregnancy loss[J]. Hum Reprod Open, 2018, 2018(2):hoy004. doi: 10.1093/hropen/hoy004. |
[6] | Radin M, Schreiber K, Cecchi I, et al. A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution[J]. Rheumatology(Oxford), 2020, 59(9):2412-2418. doi: 10.1093/rheumatology/kez620. |
[7] | Serena C, Clemenza S, Simeone S, et al. Undifferentiated Connective Tissue Disease in Pregnancy: A Topic Yet to be Explored[J]. Front Pharmacol, 2022,13:820760. doi: 10.3389/fphar.2022.820760. |
[8] |
Mosca M, Tani C, Talarico R, et al. Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases[J]. Autoimmun Rev, 2011, 10(5):256-258. doi: 10.1016/j.autrev.2010.09.013.
pmid: 20863913 |
[9] | Veglia M, D′Ippolito S, Marana R, et al. Human IgG Antinuclear Antibodies Induce Pregnancy Loss in Mice by Increasing Immune Complex Deposition in Placental Tissue: In Vivo Study[J]. Am J Reprod Immunol, 2015, 74(6):542-552. doi: 10.1111/aji.12429. |
[10] | He WR, Wei H. Maternal and fetal complications associated with systemic lupus erythematosus: An updated meta-analysis of the most recent studies (2017-2019)[J]. Medicine(Baltimore), 2020, 99(16):e19797. doi: 10.1097/MD.0000000000019797. |
[11] | Ku M, Guo S, Shang W, et al. Pregnancy Outcomes in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Retrospective Study of 109 Pregnancies[J]. PLoS One, 2016, 11(7):e0159364. doi: 10.1371/journal.pone.0159364. |
[12] | Vicoveanu P, Vasilache IA, Nemescu D, et al. Predictors Associated with Adverse Pregnancy Outcomes in a Cohort of Women with Systematic Lupus Erythematosus from Romania-An Observational Study (Stage 2)[J]. J Clin Med, 2022, 11(7):1964. doi: 10.3390/jcm11071964. |
[13] | Griffiths WJ, Wang Y. Cholesterol metabolism: from lipidomics to immunology[J]. J Lipid Res, 2022, 63(2):100165. doi: 10.1016/j.jlr.2021.100165. |
[14] |
Morikawa M, Mayama M, Saito Y, et al. Hypoproteinemia as a parameter of poor perinatal/neonatal outcomes in women with preeclampsia diagnosed as hypertension plus proteinuria[J]. Pregnancy Hypertens, 2020, 21:111-117. doi: 10.1016/j.preghy.2020.05.012.
pmid: 32492636 |
[15] | James TE, Martin LJ, Warkentin TE, et al. Catastrophic antiphospholipid syndrome refractory to high-dose intravenous immunoglobulin responsive to therapeutic plasma exchange[J]. Platelets, 2021, 32(6):828-831. doi: 10.1080/09537104.2020.1802414. |
[16] | 严晓青, 周英, 朱金伍. 免疫相关指标及核抗原抗体在系统性红斑狼疮患者中的诊断价值[J]. 医学临床研究, 2021, 38(3):359-361. doi: 10.3969/j.issn.1671-7171.2021.03.011. |
[17] | 刘晓玲, 金宇, 谢亚柳, 等. 可提取核抗原抗体、抗核抗体、体液免疫检验对系统性红斑狼疮患者诊断价值研究[J]. 临床军医杂志, 2023, 51(7):722-724. doi: 10.16680/j.1671-3826.2023.07.13. |
[18] | Garcia D, Erkan D. Diagnosis and Management of the Antiphospholipid Syndrome[J]. N Engl J Med, 2018, 378(21):2010-2021. doi: 10.1056/NEJMra1705454. |
[19] |
Liang Y, Leng RX, Pan HF, et al. Effects of Disease Activity and Inflammatory Response on Hypercoagulability in Patients with Systemic Lupus Erythematosus[J]. Arch Med Res, 2016, 47(7):573-579. doi: 10.1016/j.arcmed.2016.12.001.
pmid: 28262199 |
[20] | 李洋. 妊娠合并未分化结缔组织病对凝血功能和母儿结局的影响[D]. 太原: 山西医科大学, 2022. |
[1] | WANG Jia-yi, JI Hui, LI Xin, LING Xiu-feng. Effect of Serum β-hCG Level on the Next Day of Dual Trigger in Antagonist Regimen on the Outcome of Fresh Embryo Transfer [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 447-452. |
[2] | GAO Xiao-li, SU Jing, LI Zeng-yan, LI Jie. Clinical Analysis of 14 Cases of Pregnancy-Associated Hemolytic Uremic Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 458-461. |
[3] | WU Ying-ying, DU Xin. A Case of Full-Term Pregnancy after Single-Port Laparoscopic Debulking of Multiple Uterine Fibroids in Mid-Pregnancy [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(5): 406-409. |
[4] | LUO Sha-sha, WANG De-jing. Analysis of Influencing Factors of Frozen-Thawed Embryo Transfer Pregnancy Outcome [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(5): 420-424. |
[5] | XIE Yu-xin, WANG Rui-xue, CHEN Meng-na, CHU Ji-jun. The Role of Annexin A Family at Maternal-Fetal Interface and Related Adverse Pregnancy [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(5): 430-434. |
[6] | WU Yu-xuan, MENG Zi-fan, DONG Li, JI Hui. The Effect of Time Interval between Hysteroscopic Polypectomy and Start of Frozen-Thawed Embryo Transfer Cycles on Pregnancy Outcomes [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(4): 274-278. |
[7] | XU Xiao-yan, WANG Xiao-xuan. Diagnosis and Treatment of Three Cases of Ovarian Pregnancy Rupture [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(4): 309-312. |
[8] | LIU Fang-lei, FENG Xiao-ling. The Correlation between Thyroid-Related Hormones and Preeclampsia [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(4): 348-352. |
[9] | LI Ning, ZHANG An-ni, HE Xiao-xia, ZHANG Xue-hong. A Nomogram Prediction Model for Gestational Hypertension after Frozen Embryo Transfer [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(3): 177-184. |
[10] | WANG Dong-xue, BAO Li-li, LIU Shan, YANG Bo. Effect of Modified Flexible Antagonist Protocol on the Outcome of COH in Patients with Normal Ovarian Function [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(3): 185-189. |
[11] | XIA Meng-yao, YANG Ling, ZHAO Fei, GUO Lu-lu, WANG Feng-qing. A Case of Early Abdominal Pregnancy Rupture [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(3): 204-206. |
[12] | LI Yan-lin, HE Yin-fang. Progress in the Diagnosis and Treatment of Obstetric Antiphospholipid Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(3): 254-259. |
[13] | GU Xu-zhao, SHEN Hao-fei, GAO Min, LIU A-hui, WANG Na, YANG Wen-jing, ZHANG Xue-hong. Didelphic Uterus Combined with Ovarian Pregnancy:A Case Report [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(2): 118-120. |
[14] | LI Ting-ting, TAN Xiao-fang, SHI Wei-hong. Triplet Pregnancy Complicated by Twin Reversed Arterial Perfusion Sequence after Assisted Reproductive Technology: A Case Report and Literature Review [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(1): 24-27. |
[15] | ZHANG Tong, YE Hong. A Case of Tubal Ectopic Pregnancy with Hydatidiform Mole and Intraperitoneal Hemorrhage [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(1): 28-31. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||